Page last updated: 2024-11-04

malonic semialdehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

malonic semialdehyde: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID868
CHEBI ID17960
MeSH IDM0118887

Synonyms (27)

Synonym
3-oxopropanoic acid
formylacetic acid
CHEBI:17960
malonate semialdehyde
C00222
malonic semialdehyde
926-61-4
propanoic acid, 3-oxo-
unii-9k1t0u0r4c
9k1t0u0r4c ,
acetic acid, formyl-
3-oxopropionic acid
malonaldehydic acid
ytr 830h-iii
3-oxo-propionic acid
OAKURXIZZOAYBC-UHFFFAOYSA-N
3-oxopropanoicacid
DTXSID90239064
formyl acetic acid
3-oxidanylidenepropanoic acid
FK2 ,
FT-0745805
Q27102737
BCP29359
norepinephrine impurity 22;malonic semialdehyde;propanoic acid, 3-oxo-;formylacetic acid
SB85409
EN300-144854
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aldehydic acidA monocarboxylic acid derived from any dicarboxylic acid that has a retained name by the formal reduction of one of the carboxy groups to a formyl group. The resulting structure, also known as a semialdehyde, may be named by replacing the ending '...ic acid' of the retained name of the dicarboxylic acid by the ending '...aldehydic acid'. Aldehydic acids therefore contain one carboxy group and one aldehyde group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (16)

PathwayProteinsCompounds
Aspartate Metabolism1430
beta-Alanine Metabolism927
Propanoate Metabolism1837
Canavan Disease1430
Hypoacetylaspartia1430
GABA-Transaminase Deficiency927
Malonic Aciduria1837
Methylmalonic Aciduria Due to Cobalamin-Related Disorders1837
Ureidopropionase Deficiency927
Carnosinuria, Carnosinemia927
Malonyl-CoA Decarboxylase Deficiency1837
Uracil Degradation III616
Alanine,Aspartic acid and Asparagine metabolism ( Alanine,Aspartic acid and Asparagine metabolism )2237
2-Oxo-glutaric acid + beta-Alanine = L-Glutamic acid + Malonate semialdehyde ( Pyrimidine Nucleotides and Nucleosides metabolism )14
Biochemical pathways: part I0466
GABA metabolism (aka GHB)1128

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (35.29)18.7374
1990's3 (17.65)18.2507
2000's3 (17.65)29.6817
2010's3 (17.65)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.27 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index38.53 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.56%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]